丹麦制药巨头诺和诺德2024Q3财报 - 营收劲增24%,创新药驱动增长,战略布局稳健

读懂财报
14 Jan

诺和诺德(Novo Nordisk)是一家全球领先的医疗健康公司,创立于1923年,总部位于丹麦,以其在糖尿病和肥胖症治疗领域的突破性药物而闻名。目前,诺和诺德在全球80个国家拥有约72,000名员工,其产品销售遍及约170个国家。诺和诺德是丹麦最大的纳税公司。2022 年,该公司缴纳了 90 亿克朗(约合 13 亿美元)的企业所得税。该公司向丹麦政府缴纳的所得税在过去五年中翻了一番,从 2019...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10